{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:52:51Z","timestamp":1781002371048,"version":"3.54.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Mitochon Pharmaceutical Inc"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 NS082338"],"award-info":[{"award-number":["R01 NS082338"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.expneurol.2017.03.020","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T03:01:58Z","timestamp":1490670118000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["2,4 DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington's disease"],"prefix":"10.1016","volume":"293","author":[{"given":"Bin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2017.03.020_bb0010","first-page":"221","article-title":"Aging, neurogenesis, and caloric restriction in different model organisms","volume":"4","author":"Arslan-Ergul","year":"2013","journal-title":"Aging Dis"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0015","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0020","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1474-9726.2008.00407.x","article-title":"Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity","volume":"7","author":"Caldeira da Silva","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0030","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington's disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients","volume":"359","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0045","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2011.02.022","article-title":"Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model","volume":"56","author":"Cheng","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yrtph.2007.03.006","article-title":"Dinitrophenol and obesity: an early twentieth-century regulatory dilemma","volume":"48","author":"Colman","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0055","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresbull.2006.10.016","article-title":"Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease","volume":"72","author":"Cummings","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15216540600702198","article-title":"Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of 2,4-dinitrophenol: the gentle face of Janus","volume":"58","author":"De Felice","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0070","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40520-013-0004-2","article-title":"Cell biology of normal brain aging: synaptic plasticity-cell death","volume":"25","author":"Dorszewska","year":"2013","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P","article-title":"Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease","volume":"57","author":"Duan","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0085","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2011.10.009","article-title":"Initial experience in the treatment of inherited mitochondrial disease with EPI-743","volume":"105","author":"Enns","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1126\/science.281.5378.838","article-title":"DARPP-32: regulator of the efficacy of dopaminergic neurotransmission","volume":"281","author":"Fienberg","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0100","first-page":"938530","article-title":"Differential changes in postsynaptic density proteins in postmortem Huntington's disease and Parkinson's disease human brains","volume":"2014","author":"Fourie","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.19-01-00109.1999","article-title":"Citron, a Rho-target, interacts with PSD-95\/SAP-90 at glutamatergic synapses in the thalamus","volume":"19","author":"Furuyashiki","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00125-010-1932-4","article-title":"Targeting energy expenditure via fuel switching and beyond","volume":"54","author":"Geisler","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0115","article-title":"DNP, mitochondrial uncoupling and neuroprotection: a little dab'll do ya","author":"Geisler","year":"2016","journal-title":"Alzheimer's & dementia: the journal of the Alzheimer's Association"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1389450115666140115113734","article-title":"The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?","volume":"15","author":"Gil-Mohapel","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0125","doi-asserted-by":"crossref","first-page":"19341","DOI":"10.1074\/jbc.M114.568204","article-title":"The chemical uncoupler 2,4-dinitrophenol (DNP) protects against diet-induced obesity and improves energy homeostasis in mice at thermoneutrality","volume":"289","author":"Goldgof","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000749","article-title":"Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice","volume":"5","author":"Goula","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","article-title":"Beyond the dopamine receptor: the DARPP-32\/protein phosphatase-1 cascade","volume":"23","author":"Greengard","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/ars.2009.2934","article-title":"Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues","volume":"13","author":"Halliwell","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1194\/jlr.M010264","article-title":"Nonenzymatic free radical-catalyzed generation of 15-deoxy-Delta(12,14)-prostaglandin J(2)-like compounds (deoxy-J(2)-isoprostanes) in vivo","volume":"52","author":"Hardy","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.arr.2006.03.006","article-title":"Bioenergetics of aging and calorie restriction","volume":"5","author":"Hunt","year":"2006","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0092-8674(95)90396-8","article-title":"Neuroligin 1: a splice site-specific ligand for beta-neurexins","volume":"81","author":"Ichtchenko","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0180","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.277.5331.1511","article-title":"Binding of neuroligins to PSD-95","volume":"277","author":"Irie","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets","volume":"18","author":"Jiang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0190","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddt098","article-title":"Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease","volume":"22","author":"Jiang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/acn3.135","article-title":"Sirtuin 1 activator SRT2104 protects Huntington's disease mice","volume":"1","author":"Jiang","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-gamma agonist rosiglitazone in N171-82Q mouse model of Huntington's disease","volume":"125","author":"Jin","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0205","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1093\/hmg\/ddv016","article-title":"Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease","volume":"24","author":"Jin","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0210","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","article-title":"Antioxidants in Huntington's disease","volume":"1822","author":"Johri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0215","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/ars.2005.7.1173","article-title":"Mitochondrial uncoupling proteins in the central nervous system","volume":"7","author":"Kim-Han","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0220","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1471-4159.2005.03328.x","article-title":"The mitochondrial uncoupler 2,4-dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia","volume":"94","author":"Korde","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington's disease: the good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0230","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00004647-200204000-00007","article-title":"Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release","volume":"22","author":"Liu","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0235","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1113\/JP270543","article-title":"Calorie restriction as an intervention in ageing","volume":"594","author":"Lopez-Lluch","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0240","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0245","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.freeradbiomed.2011.06.022","article-title":"Uncoupling proteins and the control of mitochondrial reactive oxygen species production","volume":"51","author":"Mailloux","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2040-7378-3-8","article-title":"Calorie restriction and stroke","volume":"3","author":"Manzanero","year":"2011","journal-title":"Exp Transl Stroke Med"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington's disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.arr.2007.08.004","article-title":"Dietary factors, hormesis and health","volume":"7","author":"Mattson","year":"2008","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0265","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0006-291X(03)00627-2","article-title":"Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death","volume":"304","author":"Mattson","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0270","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.1999.tb07824.x","article-title":"Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases","volume":"893","author":"Mattson","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2012.09.030","article-title":"Measurement of F2- isoprostanes and isofurans using gas chromatography-mass spectrometry","volume":"59","author":"Milne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0280","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbalip.2014.10.007","article-title":"The isoprostanes\u201425 years later","volume":"1851","author":"Milne","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0285","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.52.5.1104","article-title":"Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease","volume":"52","author":"Montine","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0290","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0896-6273(00)81009-0","article-title":"CRIPT, a novel postsynaptic protein that binds to the third PDZ domain of PSD-95\/SAP90","volume":"20","author":"Niethammer","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0300","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","article-title":"Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice","volume":"29","author":"Nithianantharajah","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0305","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s10541-005-0213-1","article-title":"Uncoupler of oxidative phosphorylation prolongs the lifespan of Drosophila","volume":"70","author":"Padalko","year":"2005","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0310","article-title":"Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 knock-in mouse model of Huntington's disease","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0315","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2013.10.004","article-title":"Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler","volume":"18","author":"Perry","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0320","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.aaa0672","article-title":"Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats","volume":"347","author":"Perry","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0325","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13011-015-0034-1","article-title":"Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users","volume":"10","author":"Petroczi","year":"2015","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0330","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl","key":"10.1016\/j.expneurol.2017.03.020_bb0335","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1194\/jlr.R800037-JLR200","article-title":"Isoprostanes","volume":"50","author":"Roberts","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0340","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00018-002-8469-8","article-title":"Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation","volume":"59","author":"Roberts","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0345","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0350","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1073\/pnas.1314421111","article-title":"HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response","volume":"111","author":"Rotblat","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0355","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1523\/JNEUROSCI.3044-08.2008","article-title":"Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry","volume":"28","author":"Runne","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0360","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0365","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/tx700210j","article-title":"Oxidative stress and neurotoxicity","volume":"21","author":"Sayre","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0370","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0375","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12640-009-9133-y","article-title":"Expression profile of rat hippocampal neurons treated with the neuroprotective compound 2,4-dinitrophenol: up-regulation of cAMP signaling genes","volume":"18","author":"Sebollela","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0380","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.1937.02780250024006","article-title":"Dinitrophenol and desiccated thyroid in the treatment of obesity","volume":"108","author":"Simkins","year":"1937","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0385","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0390","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.freeradbiomed.2014.05.015","article-title":"Caloric restriction and the aging process: a critique","volume":"73","author":"Sohal","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0395","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1073\/pnas.96.3.1100","article-title":"Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses","volume":"96","author":"Song","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0400","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1427.008","article-title":"Evidence of oxidant damage in Huntington's disease: Translational strategies using antioxidants","volume":"1147","author":"Stack","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0405","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1523\/JNEUROSCI.23-13-05503.2003","article-title":"Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression","volume":"23","author":"Stein","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0410","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0415","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","article-title":"DARPP-32: an integrator of neurotransmission","volume":"44","author":"Svenningsson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0420","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","article-title":"In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0425","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases","volume":"145","author":"Trushina","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0430","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/jm200605a","article-title":"Important role of oxidative stress biomarkers in Huntington's disease","volume":"54","author":"Tunez","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0435","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington's disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0440","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JHD-130080","article-title":"Striatal synaptosomes from Hdh140Q\/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation","volume":"2","author":"Valencia","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.expneurol.2017.03.020_bb0445","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0450","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0455","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2011.04.032","article-title":"Mitochondrial uncoupling agents antagonize rotenone actions in rat substantia nigra dopamine neurons","volume":"1395","author":"Wu","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2017.03.020_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075108","article-title":"Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice","volume":"8","author":"Young","year":"2013","journal-title":"PLoS One"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617300808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617300808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T09:13:31Z","timestamp":1601802811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488617300808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":92,"alternative-id":["S0014488617300808"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.03.020","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2,4 DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}